Skip to main content
Quest Diagnostics

Randomized Phase 2 Study of Digital Life Coaching During Transplantation for Myeloma

Randomized Phase 2 Study of Digital Life Coaching During Transplantation for Myeloma

Authors: Banerjee R, Huang CY, Ryan C, Lee A, Brassil KJ, Moore J, Arora S, Chung A, Wong SW, Wolf J, Martin T, Dhruva A, Shah N

Citation: Bone Marrow Transplant. 2023 Sep 25. doi: 10.1038/s41409-023-02091-4. Online ahead of print.

Specialties: Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by Pack Health, a subsidiary of Quest Diagnostics.

Related content

Conference Presentation
Impact of Goal Setting in a Digital Health Coaching Program for Participants with Type 2 Diabetes
Publication
Impact of a Digital Diabetes Prevention Program on Risk factors for Chronic Disease in a Workforce Cohort
Publication
A Pilot Feasibility Study of Digital Health Coaching for Men With Prostate Cancer
On-Demand Webinar
Hemepath Master Class Myeloid Neoplasms MPN MDS AML
On-Demand Webinar
Rethinking the Basics of Post-transplant Infections
Test FAQ
Donor Testing

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.